Overview of novel nanobiosensors for electrochemical and optical diagnosis of leukemia: Challenge and opportunity

Abstract

Leukemia is one of the ten types of cancer that causes the biggest death in the world. Compared to other types of cancer, leukemia has a low life expectancy, so an early diagnosis of the cancer is necessary. A new strategy has been developed to identify various leukemia biomarkers by making blood cancer biosensors, especially by developing nanomaterial applications so that they can improve the performance of the biosensor. Although many biosensors have been developed, the detection of leukemia by using nanomaterials with electrochemical and optical methods is still less carried out compare to other types of cancer biosensors. Even the acoustic and calorimetric testing methods for the detection of leukemia by utilizing nanomaterials have not yet been carried out. Most of the reviewed works reported the use of gold nanoparticles and electrochemical characterization methods for leukemia detection with the object of study being conventional cancer cells. In order to be used clinically by the community, future research must be carried out with a lot of patient blood objects, develop non-invasive leukemia detection, and be able to detect all types of blood cancer specifically with one biosensor. This can lead to a fast and accurate diagnosis thus allowing for early treatment and easy periodic condition monitoring for various types of leukemia based on its biomarker and future design controlable via internet of things (IoT) so that why would be monitoring real times.